Restem Group

Restem Group is a leading clinical-stage biopharmaceutical company focused on discovering and developing patient-specific and off-the-shelf next-generation cell therapies designed to activate and enhance patients' own immune systems. Our therapies aim to treat various debilitating diseases, thereby improving patient outcomes and the overall health of patients worldwide.